by H Ali | Nov 28, 2025 | Clinician Newsletters, Newsletters
2025 Annual Update Welcome to the 2025 update. BADBIR is a world leading pharmacovigilance Register for psoriasis built through the collective effort of the UK and Ireland dermatology community. While we prepare an accessible version of the update available here, you...
by H Ali | Sep 15, 2025 | News
BDNG Annual Conference 2025, Harrogate Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, Catherine H Smith, Richard B Warren, Christopher E M Griffiths, BADBIR study groupBritish Journal of Dermatology, ljaf017, https://doi.org/10.1093/bjd/ljaf017 ← Previous Next...
by H Ali | Jul 18, 2025 | News
Taltz (ixekizumab) recruitment ends on 31st July 2025 Please be aware that BADBIR cannot accept any new registrations at baseline for patients starting Taltz after 31st July. Participants must have started treatment and provided consent before 1st August to be...
by H Ali | Jul 18, 2025 | Uncategorised
BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...
by H Ali | May 29, 2025 | News
BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...
